Andrés Esteban, Eva Barcena García, Carmen Ciruelos Gil, Eva María Cortés-Funes Castro, Hernán
Behaviour of breast cancer molecular subtypes through tumour progression. [artículo] - Clinical & Translational Oncology, 2012 - 14(6):481-5.
Formato Vancouver:
Castañeda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Behaviour of breast cancer molecular subtypes through tumour progression. Clin Transl Oncol. 2012 Jun;14(6):481-5.
PMID: 22634538
Contiene 25 referencias
INTRODUCTION Breast cancer (BC) becomes more aggressive throughout disease progression. Clinical stage is correlated with patient outcome. We hypothesised that BC molecular subtypes are associated with a poor prognosis in advanced clinical stages. We analysed the distribution and behaviour of molecular subtypes at different BC tumour size and variation of molecular subtype in recurrent lesions.
Behaviour of breast cancer molecular subtypes through tumour progression. [artículo] - Clinical & Translational Oncology, 2012 - 14(6):481-5.
Formato Vancouver:
Castañeda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Behaviour of breast cancer molecular subtypes through tumour progression. Clin Transl Oncol. 2012 Jun;14(6):481-5.
PMID: 22634538
Contiene 25 referencias
INTRODUCTION Breast cancer (BC) becomes more aggressive throughout disease progression. Clinical stage is correlated with patient outcome. We hypothesised that BC molecular subtypes are associated with a poor prognosis in advanced clinical stages. We analysed the distribution and behaviour of molecular subtypes at different BC tumour size and variation of molecular subtype in recurrent lesions.
